Quantification of Breast Tumor Microvascular Permeability with Feruglose-enhanced MR Imaging: Initial Phase II Multicenter Trial

Radiology

Volumn 229, Issue 3, 2003, Pages 885-892

  Daldrup Link, Heike E ^a   Rydland, Jana ^b   Helbich, Thomas H ^c   Bjørnerud, Atle ^d   Turetschek, Karl ^c   Kvistad, Kjell Arne ^b   Kaindl, Elisabeth ^c   Link, Thomas M ^a   Staudacher, Karin ^e   Shames, David ^f   Brasch, Robert C ^f   Haraldseth, Olav ^b   Rummeny, Ernst J ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF VIENNA   (Austria)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e STATISTICS NORWAY   (Norway)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast neoplasms, MR; Iron; Magnetic resonance (MR), contrast media

Indexed keywords

CONTRAST MEDIUM; FERUGLOSE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD VESSEL PERMEABILITY; BREAST PAPILLOMA; CANCER GRADING; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PLASMA VOLUME; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CAPILLARY PERMEABILITY; CONTRAST MEDIA; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OXIDES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 10744225755     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2293021045     Document Type: Article

References (42)

1. Kaiser W, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989; 170: 681-686.
2. Heywang-Köbrunner S, Beck R, Lommatsch B. Contrast enhanced MR imaging of the breast: survey of 1200 patient examinations. Radiology 1992; 185:246-252.
3. Heywang-Köbrunner S. Contrast enhanced MR imaging of the breast. Invest Radiol 1994; 29:94-109.
4. Helbich T, Roberts T, Gossmann A, et al. Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods. Magn Reson Med 2000; 44:915-924.
5. Greenstein Orel S, Schnall M, LiVolsi V, Troupin R. Suspicious breast lesions: MR imaging with pathologic correlation. Radiology 1994; 190:485-493.
6. Kelcz F, Santyr GE, Mongin SJ, Fairbanks EJ. Reducing false positive gadolinium enhanced breast MRI results through parameter analysis of the enhancement profile (abstr). In: Proceedings of the 12th Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1993; 121.
7. Kaiser W, Reiser M. False positive cases in dynamic MR mammography (abstr). Radiology 1992; 185(P):934.
8. Heywang-Köbrunner S, Bick U, Bradley W Jr, et al. International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MR imaging based on 519 histopathologically correlated lesions. Eur Radiol 2001; 11:531-546.
9. Daldrup H, Shames D, Wendland M, et al. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small molecular contrast media. AJR Am J Roentgenol 1998; 171:941-949.
10. Brasch R, Shames D, Cohen F, et al. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas. Invest Radiol 1994; 29(suppl 2):8-11.
11. Shames D, Kuwatsuru R, Vexler V, Muehler A, Brasch R. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative non-invasive technique. Magn Reson Med 1993; 29:616-622.
12. Taylor A, Panting J, Keegan J, et al. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography. J Magn Reson Imaging 1999; 9:220-227.
13. Turetschek K, Huber S, Floyd E, et al. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. Radiology 2001; 218:562-569.
14. Weidner N, Semple J, Welch W, Folkmann J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
15. Kellar K, Jujii D, Guther W, et al. "NC100150 injection," a preparation of optimized iron oxide nanoparticles for positive contrast MR angiography. J Magn Reson Imaging 2000; 11:488-494.
16. Saeed M, Wendland M, Engelbrecht M, Sakuma H, Higgins C. Value of blood-pool contrast agents in magnetic resonance angiography of the pelvis and lower extremities. Eur Radiol 1998; 8:1047-1053.
17. Johansson L, Akeson P, Ragnarsson A, Ahlström H. Myocardial perfusion using a new superparamagnetic iron oxide (abstr). In: Proceedings of the Sixth Scientific Meeting of the International Society for Magnetic Resonance in Medicine 1998. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1998; 903.
18. Doussal VL, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). Cancer 1989; 64:1914-1921.
19. Howel L, Gandour-Edwards R, O'Sullivan D. Application of the Scarff-Bloom-Richardson tumor grading system to fine needle aspirates of the breast. Am J Clin Pathol 1994; 101:262-265.
20. Roberts TPL. Physiologic measurements by contrast-emhanced MR imaging: expectations and limitations. J Magn Reson Imaging 1997; 7:82-90.
21. Cobelli C, Foster D, Toffolo G. Tracer kinetics in biomedical research: from data to model. Dordrecht, the Netherlands: Kluwer Academic/Plenum, 2000.
22. Patlak C, Blasberg R, Fenstermacher J. Graphical evaluation of blood-to-brain transfer constants from multiple time uptake data. J Cereb Blood Flow Metab 1983; 3:1-7.
23. Patlak C, Blasberg R. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab 1985; 5:584-590.
24. Groscurth P, Kristler G. Human renal cell carcinoma in the nude mouse: long term observations. Beitr Pathol 1977; 160:337-360. (German)
25. Jain R. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987; 6:559-593.
26. Jain R. Determinants of tumor blood flow: a review. Cancer Res 1988; 48:2641-2658.
27. Warren B. The ultrastructure of the advancing edge of Walker 256 carcinoma. Microvasc Res 1970; 2:443-453.
28. Warren B, Chauvin W. Transmission and scanning electron microscopy of renal adenocarcinomas. Ann R Coll Phys Surg Can 1977; 10:74.
29. Vogel A. Intratumoral vascular changes with increased size of a mammary tumor: new methods and results. J Natl Cancer Inst 1965; 34:571-578.
30. Turetschek K, Roberts T, Floyd E, et al. Tumor microvascular characterization using ultra small superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model. J Magn Reson Imaging 2001; 13:882-888.
31. Dvorak H, Nagy J, Dvorak J, Dvorak A. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988; 133:95-109.
32. Gullino P, Grantham F. The vascular space of growth tumors. Cancer Res 1964; 24:1727-1732.
33. Hilmas D, Gillette E. Morphometric analysis of the microvasculature of tumors during growth and after irradiation. Cancer 1974; 33:103-110.
34. Boucher Y, Jain R. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 1992; 52:5110-5114.
35. Folkman J. Angiogenesis and breast cancer. J Clin Oncol 1994; 12:441-443.
36. Brasch R, Li K, Husband J, et al. In vivo monitoring of tumor angiogenesis with MR Imaging. Acad Radiol 2000; 7:812-823.
37. Jain R. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 1990; 9:253-266.
38. Jain R. Barriers to drug delivery in solid tumors. Sci Am 1994; 271:58-65.
39. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996; 200:639-649.
40. Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Garrido L. Breast cancer: regional blood flow and blood volume measured with magnetic susceptibility-based MR imaging-initial results. Radiology 2002; 223: 558-565.
41. Kinkel K, Hylton NM. Challenges to interpretation of breast MRI. J Magn Reson Imaging 2001; 13:821-829.
42. Brasch R, Berthezene Y, Vexler V, et al. Pulmonary oxygen toxicity: demonstration of abnormal capillary permeability using contrast enhanced MRI. Pediatr Radiol 1993; 23:495-500.